3 Essential Factors for Bringing Continuous Glucose Monitoring to Primary Care

News | May 2nd, 2022

1 in 10 people in the United States have diabetes. With the growing prevalence, primary care providers are an essential part of the care team, managing treatment plans for many people living with diabetes. Patients are making decisions about their diabetes many times throughout every day. Until now, we have lacked the technology and connectivity to enable providers to better support this decision making.

Continuous Glucose Monitors (CGM) provide rich insights into inter- and intra-day patterns that can help clinicians make more personalized and precise recommendations on medication as well as lifestyle changes. Yet, many primary care providers are not yet familiar with interpreting the data that CGM provides.

As insurance coverage for CGM continues to grow, three things will be key to ensuring this technology improves outcomes for people living with diabetes: CGM data connectivity to the EHR, CGM data connectivity to the entire care team, and Clinical Decision Support tools to empower providers to interpret CGM data and make personalized treatment recommendations.

Rimidi Brings CGM Data Into Clinical Workflows

With a diverse ecosystem of medical device integrations, including Continuous Glucose Monitors, Rimidi enables providers to realize the goal of Remote Patient Monitoring – better patient outcomes. Rimidi combines data from CGM and other medical devices with other relevant patient data from the EHR, and embeds clinical decision support in the EHR workflow to drive positive impacts for patients.

Rimidi can integrate CGM data into your EHR Workflow. Learn More.